The company shall also file the final report of forensic audit with comments of the management, if any, as per regulations, says a notification to the exchange

Amrutanjan initiates forensic audit after whistleblower complaint on lapses involving senior employees

Amrutanjan shares fall 8.15% as company initiates forensic investigation to probe allegation of lapses by some employees

Stocks to watch out for are Amrutanjan, LT Foods, Vodafone Idea, Paytm, and Phoenix Mills

Stocks that will see action on February 15, 2023

Stocks to watch: Titan, CIpla, Wipro, Amrutanjan, Chochin Shipyard, Indigo, Shipping Corp, Chemplast Sanmar, City Union Bank, Dreamfolks Services, Escorts Kubota, GAIL India, Go Fashion (India), Godrej Agro, Marico, Puravankara, TTK Prestiege, TVS Motor Company and Wockhardt

Stocks that will see action on November 04, 2022

Comfy PPRO is a unique product that helps consumers relieve pain during their periods. It is a 100% Ayurvedic product available in 50ml bottle. The unique roller ball applicator offers hands free, non-messy application. The non-sticky, non-staining

Amrutanjan Health Care launches 100% ayurvedic product - Comfy PPRO

Reports the quarter as ‘perfect storm’ as revenue falls

Amrutanjan reports lower net profit in Q122

Amrutanjan Heal Standalone March 2022 Net Sales at Rs 106.55 crore, up 13.33% Y-o-Y

Amrutanjan posts ₹67 crore profit in FY22

Buzzing stocks: Adani Ports, Olectra, Marico, Maruti, Natco Pharma, Pitti Engineering, Schaeffler, Rupa, Khaitan Chem, Apex Frozen, Bank of India, Amrutanjan, Grasim, Latent View, Zee Media

Stocks that will see action today (May 24)

Amrutanjan net profit flat in Q3

Buzzing stocks: ONGC, Jet Airways, OIL, Nazara Technologies, 63 moons technologies, Glenmark, Amrutanjan, Apollo Hospitals, Ashok Leyland, Divis Labs, Future Lifestyle Fashions, GRSE, Hudco, IDFC, IFCI, India Cements, Indigo Paints, PFC, Sobha, Star Health, Voltas, VA Tech Wabag, Burger King, Torren…

Stocks that will see action today (February 11)

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.